Zelira Therapeutics Ltd has released a press release.
Transformative US$33M Fundraising into Zeliras HOPE 1 SPV
Earlier from Zelira Therapeutics
- Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund
- Preliminary Final Report
- Zelira Therapeutics Secures R&D Loan Facility
- Publication of ZLT-L-007 IRB Approved Observational Study